Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6094
0.00 (0.00%)
Feb 13, 2026, 4:00 PM EST - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $4.26 million as of February 17, 2026. Its market cap has decreased by -79.36% in one year.
Market Cap
4.26M
Enterprise Value
-9.46M
1-Year Change
-79.36%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $4.26M, a decrease of -77.49%. That is a compound annual growth rate of -33.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.26M | -28.56% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 4.98M |
| Silexion Therapeutics | 4.97M |
| Bio Green Med Solution | 4.81M |
| Cyclerion Therapeutics | 4.76M |
| Decoy Therapeutics | 4.72M |
| Genprex | 4.68M |
| 60 Degrees Pharmaceuticals | 4.52M |
| Galmed Pharmaceuticals | 4.03M |